Camostat mesilate(Kangen)

N/A

Report date: 2025/09/03 14:11:14

Base Information

Drug NameCamostat mesilate(Kangen)
Drug Alias NameNI-03
ClassificationSmall molecules
Mechanisms of ActionProtease inhibitors
TargetsProtease
Therapy Area/IndicationsPancreatitis, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUkraineRussian Federation
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesStason Pharma
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPancreatitis, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A